2019
DOI: 10.1016/j.earlhumdev.2019.01.008
|View full text |Cite
|
Sign up to set email alerts
|

Neonatal outcomes of antenatal corticosteroids in preterm multiple pregnancies compared to singletons

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
9
0
2

Year Published

2020
2020
2023
2023

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 11 publications
(11 citation statements)
references
References 40 publications
0
9
0
2
Order By: Relevance
“…Although the efficacy of incomplete ACS was shown by a previous study conducted in singletons, 46 it remained challenged by gestational age at delivery. 47 Herrera et al 21 did not show a significant reduction in the risks of death and RDS among multiple gestations exposed to incomplete ACS. The ACS administration-to-delivery interval was also regarded as a source of heterogeneity, since a significant reduction of RDS and PVL was found among preterm twins delivered within 7 days after administration but not among those without information on administration timing.…”
Section: Open Accessmentioning
confidence: 89%
See 1 more Smart Citation
“…Although the efficacy of incomplete ACS was shown by a previous study conducted in singletons, 46 it remained challenged by gestational age at delivery. 47 Herrera et al 21 did not show a significant reduction in the risks of death and RDS among multiple gestations exposed to incomplete ACS. The ACS administration-to-delivery interval was also regarded as a source of heterogeneity, since a significant reduction of RDS and PVL was found among preterm twins delivered within 7 days after administration but not among those without information on administration timing.…”
Section: Open Accessmentioning
confidence: 89%
“…13 14 While the efficacy of ACS treatment in singletons is supported by abundant evidence, the current evidence in multiple gestations is limited and less consistent. [15][16][17][18][19][20][21][22][23][24][25] Strengths and limitations of this study ► This is a meta-analysis investigating the benefits of antenatal corticosteroids (ACS) in preterm multiple gestations since this group is not addressed separately in previous systematic reviews. ► We aimed to generate pooled estimates of effect of ACS on important outcomes of newborns in multiple pregnancies.…”
Section: Introductionmentioning
confidence: 99%
“…A large cohort study found that twins showed a similar reduction in short‐term respiratory morbidity, NND and neurological injury compared with singletons when corticosteroids were given 1–7 days before birth, but no reduction in other morbidities 127 . This reduction in respiratory morbidity was supported by the findings of a more recent study 128 , but was contradicted by others in which no such improvement in short‐term morbidity was observed, but with a possible reduction in neonatal mortality 129,130 . A proposed explanation for the questionable benefit of corticosteroids in twins may be due to the shorter half‐life of betamethasone observed in mothers of twins compared with mothers of singletons (7.2 ± 2.4 h vs 9.0 ± 2.7 h; P = 0.017) 131 .…”
Section: Role Of Corticosteroidsmentioning
confidence: 88%
“…34 Future reviews could benefit from a systematic search of nonrandomized studies that include higher-order multiples, because we identified several studies in multiples that did not provide disaggregated data on twins during our search. [35][36][37][38][39][40] Existing guidelines and consensus recommending antenatal corticosteroid administration in twins are based on limited evidence from randomized trials, select observational studies, and extrapolation from studies on singletons. This review showed general agreement among nonrandomized studies that antenatal corticosteroids are associated with lower incidence of neonatal mortality and RDS.…”
Section: Discussionmentioning
confidence: 99%